CEO Of Daiichi Sankyo U.S. Unit Steps Down, Replaced By Gormley
This article was originally published in PharmAsia News
Daiichi Sankyo named Glenn Gormley president and chairman of its U.S. unit, replacing John Gargiulo, who it said was stepping down from his roles as president and CEO and head of the company's commercial division.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.